JENNIFER CHILDRESS: Open Payments
NPI 1184166068 · HAYS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 92 payments from 22 companies in 2025. Trend: 2023 $1,230 · 2024 $1,454 · 2025 $1,539
Food & beverage: $1,539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $242 |
| AstraZeneca Pharmaceuticals LP | 12 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $126 |
| Lilly USA, LLC | 4 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 5 | $82 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Viatris Specialty LLC | 3 | $57 |
| ANI Pharmaceuticals, Inc. | 3 | $57 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Kerendia, VOQUEZNA, TRELEGY ELLIPTA, BREZTRI, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
